• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经节苷脂 GM1 与中枢神经系统。

Ganglioside GM1 and the Central Nervous System.

机构信息

Department of Chemistry, University of Florida, Gainesville, FL 32611, USA.

出版信息

Int J Mol Sci. 2023 May 31;24(11):9558. doi: 10.3390/ijms24119558.

DOI:10.3390/ijms24119558
PMID:37298512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10253378/
Abstract

GM1 is one of the major glycosphingolipids (GSLs) on the cell surface in the central nervous system (CNS). Its expression level, distribution pattern, and lipid composition are dependent upon cell and tissue type, developmental stage, and disease state, which suggests a potentially broad spectrum of functions of GM1 in various neurological and neuropathological processes. The major focus of this review is the roles that GM1 plays in the development and activities of brains, such as cell differentiation, neuritogenesis, neuroregeneration, signal transducing, memory, and cognition, as well as the molecular basis and mechanisms for these functions. Overall, GM1 is protective for the CNS. Additionally, this review has also examined the relationships between GM1 and neurological disorders, such as Alzheimer's disease, Parkinson's disease, GM1 gangliosidosis, Huntington's disease, epilepsy and seizure, amyotrophic lateral sclerosis, depression, alcohol dependence, etc., and the functional roles and therapeutic applications of GM1 in these disorders. Finally, current obstacles that hinder more in-depth investigations and understanding of GM1 and the future directions in this field are discussed.

摘要

GM1 是中枢神经系统(CNS)细胞表面的主要糖脂(GSL)之一。其表达水平、分布模式和脂质组成依赖于细胞和组织类型、发育阶段和疾病状态,这表明 GM1 在各种神经和神经病理过程中具有广泛的潜在功能。本篇综述的主要重点是 GM1 在大脑发育和活动中的作用,例如细胞分化、神经突生成、神经再生、信号转导、记忆和认知,以及这些功能的分子基础和机制。总的来说,GM1 对中枢神经系统具有保护作用。此外,本文还研究了 GM1 与神经紊乱之间的关系,例如阿尔茨海默病、帕金森病、GM1 神经节苷脂病、亨廷顿病、癫痫和发作、肌萎缩侧索硬化症、抑郁症、酒精依赖症等,以及 GM1 在这些疾病中的功能作用和治疗应用。最后,讨论了目前阻碍更深入研究和理解 GM1 的障碍以及该领域的未来发展方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/0c5f20200b92/ijms-24-09558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/f39b7010f264/ijms-24-09558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/a68b948ce9d2/ijms-24-09558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/73600a15ad06/ijms-24-09558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/f025a2f81c00/ijms-24-09558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/0c5f20200b92/ijms-24-09558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/f39b7010f264/ijms-24-09558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/a68b948ce9d2/ijms-24-09558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/73600a15ad06/ijms-24-09558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/f025a2f81c00/ijms-24-09558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/034e/10253378/0c5f20200b92/ijms-24-09558-g005.jpg

相似文献

1
Ganglioside GM1 and the Central Nervous System.神经节苷脂 GM1 与中枢神经系统。
Int J Mol Sci. 2023 May 31;24(11):9558. doi: 10.3390/ijms24119558.
2
Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model.从 GM1 神经节苷脂贮积症小鼠模型中枢神经系统细胞的单细胞转录组分析中获得的对其病理生物学的深入了解。
Int J Mol Sci. 2024 Sep 8;25(17):9712. doi: 10.3390/ijms25179712.
3
Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.溶酶体酸性β-半乳糖苷酶缺陷小鼠的全身性中枢神经系统疾病和大量GM1神经节苷脂蓄积
Hum Mol Genet. 1997 Feb;6(2):205-11. doi: 10.1093/hmg/6.2.205.
4
Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.正常个体和β-半乳糖苷酶缺乏症患者培养成纤维细胞中GM1神经节苷脂和脱唾液酸GM1神经节苷脂的掺入与降解
Biochim Biophys Acta. 1986 Jan 3;875(1):115-21.
5
Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content.通过 GM1 神经节苷脂含量评估对 GM1 神经节苷脂贮积症和相关疾病进行预诊断和管理。
Sci Rep. 2019 Nov 27;9(1):17684. doi: 10.1038/s41598-019-53995-5.
6
Characterization of neutral and acidic glycosphingolipids in brains of two patients with GM1 gangliosidosis type 1 and type 2.两名1型和2型GM1神经节苷脂贮积症患者大脑中中性和酸性糖鞘脂的特征分析。
J Neurochem. 1985 Apr;44(4):1100-6. doi: 10.1111/j.1471-4159.1985.tb08730.x.
7
Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation.新型药物候选物通过自噬激活改善 GM1 神经节苷脂贮积症模型中的神经节苷脂积累和神经功能障碍。
Stem Cell Reports. 2020 May 12;14(5):909-923. doi: 10.1016/j.stemcr.2020.03.012. Epub 2020 Apr 16.
8
Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.脑脊液生物标志物显示GM1神经节苷脂贮积症犬存在神经退行性变:在评估治疗方案中的可能用途
Brain Res. 2007 Feb 16;1133(1):200-8. doi: 10.1016/j.brainres.2006.11.039. Epub 2006 Dec 28.
9
Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.来自对照个体和GM1神经节苷脂沉积症患者的皮肤成纤维细胞中放射性标记的GM1神经节苷脂的摄取与代谢
J Inherit Metab Dis. 1991;14(5):721-9. doi: 10.1007/BF01799941.
10
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.大脑中的神经节苷脂:生理学、病理生理学及治疗应用
Front Neurosci. 2020 Oct 6;14:572965. doi: 10.3389/fnins.2020.572965. eCollection 2020.

引用本文的文献

1
Deficiency of Ugcg in LSECs alleviates high-fat diet-induced MASLD.肝窦内皮细胞中Ugcg的缺乏可缓解高脂饮食诱导的代谢相关脂肪性肝病。
Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000793. eCollection 2025 Sep 1.
2
Systemic Metabolic Alterations Induced by Etodolac in Healthy Individuals.依托度酸在健康个体中诱导的全身代谢改变。
Pharmaceuticals (Basel). 2025 Aug 4;18(8):1155. doi: 10.3390/ph18081155.
3
SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy.SC134-德卢替康,一种靶向岩藻糖基化GM1的抗体偶联药物,用于小细胞肺癌治疗。

本文引用的文献

1
The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.脑 GM1 神经节苷脂耗竭与帕金森病的关系。
FEBS Open Bio. 2023 Sep;13(9):1548-1557. doi: 10.1002/2211-5463.13554. Epub 2023 Feb 5.
2
The Key Role of GM1 Ganglioside in Parkinson's Disease.GM1 神经节苷脂在帕金森病中的关键作用。
Biomolecules. 2022 Jan 21;12(2):173. doi: 10.3390/biom12020173.
3
Novel insights on GM1 and Parkinson's disease: A critical review.GM1 与帕金森病的新见解:批判性回顾。
J Transl Med. 2025 Aug 19;23(1):940. doi: 10.1186/s12967-025-06940-2.
4
Emerging targets and translational challenges in treating paclitaxel-induced peripheral neuropathy.治疗紫杉醇引起的周围神经病变的新靶点及转化挑战
Mol Biol Rep. 2025 Aug 18;52(1):833. doi: 10.1007/s11033-025-10938-w.
5
GM1 Oligosaccharide Modulates Microglial Activation and α-Synuclein Clearance in a Human In Vitro Model.GM1寡糖在人源体外模型中调节小胶质细胞激活及α-突触核蛋白清除
Int J Mol Sci. 2025 Aug 7;26(15):7634. doi: 10.3390/ijms26157634.
6
Therapeutics Potential of Cronassial in Experimental Autoimmune Encephalomyelitis: Insights Into Glycosphingolipids and Humoral Immunity.克诺萨ial在实验性自身免疫性脑脊髓炎中的治疗潜力:对糖鞘脂和体液免疫的见解
ScientificWorldJournal. 2025 Jul 18;2025:9108462. doi: 10.1155/tswj/9108462. eCollection 2025.
7
Unraveling the GM Specificity of Galectin‑1 Binding to Lipid Membranes.解析半乳糖凝集素-1与脂质膜结合的GM特异性
ACS Bio Med Chem Au. 2025 May 7;5(3):415-426. doi: 10.1021/acsbiomedchemau.5c00040. eCollection 2025 Jun 18.
8
Efficacy of sialic acid supplementation in early life in autism model rats.早期补充唾液酸对自闭症模型大鼠的疗效。
Sci Rep. 2025 Mar 12;15(1):8576. doi: 10.1038/s41598-025-93550-z.
9
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis.GM1和GM2神经节苷脂贮积症中药效学生物标志物格局的评估。
Clin Transl Sci. 2025 Mar;18(3):e70176. doi: 10.1111/cts.70176.
10
Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications.神经退行性疾病中的髓磷脂脂质改变:概况与致病意义
Antioxid Redox Signal. 2024 Dec;41(16-18):1073-1099. doi: 10.1089/ars.2024.0676. Epub 2024 Nov 22.
Glycoconj J. 2022 Feb;39(1):27-38. doi: 10.1007/s10719-021-10019-7. Epub 2022 Jan 22.
4
Anti-inflammatory role of GM1 and other gangliosides on microglia.GM1 及其他神经节苷脂对小胶质细胞的抗炎作用。
J Neuroinflammation. 2022 Jan 6;19(1):9. doi: 10.1186/s12974-021-02374-x.
5
Systemic deficiency of GM1 ganglioside in Parkinson's disease tissues and its relation to the disease etiology.帕金森病组织中 GM1 神经节苷脂的全身性缺乏及其与疾病病因的关系。
Glycoconj J. 2022 Feb;39(1):75-82. doi: 10.1007/s10719-021-10025-9. Epub 2022 Jan 1.
6
Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.质膜钙 ATP 酶-神经钙黏蛋白复合物在含有 GM1 的脂筏中被选择性稳定。
Int J Mol Sci. 2021 Dec 18;22(24):13590. doi: 10.3390/ijms222413590.
7
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.糖脂代谢及其在衰老和帕金森病中的作用。
Glycoconj J. 2022 Feb;39(1):39-53. doi: 10.1007/s10719-021-10023-x. Epub 2021 Nov 10.
8
GM1 Gangliosidosis-A Mini-Review.GM1神经节苷脂贮积症——一篇小型综述。
Front Genet. 2021 Sep 3;12:734878. doi: 10.3389/fgene.2021.734878. eCollection 2021.
9
Therapeutic Uses of Bacterial Subunit Toxins.细菌亚基毒素的治疗用途
Toxins (Basel). 2021 May 26;13(6):378. doi: 10.3390/toxins13060378.
10
GM1 Gangliosidosis: Mechanisms and Management.GM1神经节苷脂贮积症:发病机制与治疗
Appl Clin Genet. 2021 Apr 9;14:209-233. doi: 10.2147/TACG.S206076. eCollection 2021.